211 related articles for article (PubMed ID: 28342679)
1. Pharmacogenomic aspects of bipolar disorder: An update.
Budde M; Degner D; Brockmöller J; Schulze TG
Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679
[TBL] [Abstract][Full Text] [Related]
2. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
3. Twenty years of Lithium pharmacogenetics: A systematic review.
Pagani R; Gasparini A; Ielmini M; Caselli I; Poloni N; Ferrari M; Marino F; Callegari C
Psychiatry Res; 2019 Aug; 278():42-50. PubMed ID: 31146140
[TBL] [Abstract][Full Text] [Related]
4. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C; Heilbronner U; Squassina A
Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
[TBL] [Abstract][Full Text] [Related]
5. Can the response to mood stabilizers be predicted in bipolar disorder?
Geoffroy PA; Bellivier F; Leboyer M; Etain B
Front Biosci (Elite Ed); 2014 Jan; 6(1):120-38. PubMed ID: 24389147
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of lithium response in bipolar disorder.
McCarthy MJ; Leckband SG; Kelsoe JR
Pharmacogenomics; 2010 Oct; 11(10):1439-65. PubMed ID: 21047205
[TBL] [Abstract][Full Text] [Related]
7. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
8. Innovative approaches to bipolar disorder and its treatment.
Harrison PJ; Cipriani A; Harmer CJ; Nobre AC; Saunders K; Goodwin GM; Geddes JR
Ann N Y Acad Sci; 2016 Feb; 1366(1):76-89. PubMed ID: 27111134
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.
Murphy E; McMahon FJ
Discov Med; 2013 Sep; 16(87):113-22. PubMed ID: 23998447
[TBL] [Abstract][Full Text] [Related]
10. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic aspects of bipolar disorder.
Alda M
Pharmacogenomics; 2003 Jan; 4(1):35-40. PubMed ID: 12517284
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of bipolar disorder.
Severino G; Squassina A; Costa M; Pisanu C; Calza S; Alda M; Del Zompo M; Manchia M
Pharmacogenomics; 2013 Apr; 14(6):655-74. PubMed ID: 23570469
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics and bipolar disorder.
Mamdani F; Groisman IJ; Alda M; Turecki G
Pharmacogenomics J; 2004; 4(3):161-70. PubMed ID: 15079146
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
Geoffroy PA; Bellivier F; Henry C
Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
[TBL] [Abstract][Full Text] [Related]
15. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
16. Response to lithium in bipolar disorder: clinical and genetic findings.
Rybakowski JK
ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response to drug therapy in psychiatric disorders.
Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH
Open Biol; 2018 May; 8(5):. PubMed ID: 29794033
[TBL] [Abstract][Full Text] [Related]
18. Lithium in the treatment of manic-depressive illness: an update. Proceedings of a meeting. Sea Island, Georgia, USA. May 30-31, 1997.
J Clin Psychiatry; 1998; 59 Suppl 6():3-82. PubMed ID: 9687239
[No Abstract] [Full Text] [Related]
19. Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.
Smith DJ; Evans R; Craddock N
J Ment Health; 2010 Apr; 19(2):142-56. PubMed ID: 20433322
[TBL] [Abstract][Full Text] [Related]
20. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
